| Jul 3 |
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
|
| Jul 2 |
Annovis doubles as lead drug improves Parkinson’s
|
| Jul 2 |
Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap
|
| Jun 30 |
Annovis: Strong Sell Reiteration Prior To Phase 3 Data In Parkinson's Disease
|
| Jun 28 |
Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
|
| Jun 27 |
CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
|
| Jun 27 |
Annovis Bio files patent for new manufacturing process of buntanetap
|
| Jun 27 |
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
|
| Jun 26 |
ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why
|
| Jun 26 |
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
|
